AMANDA POWERS: Open Payments
NPI 1588997357 · SUN CITY WEST, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 45 payments from 17 companies in 2025. Trend: 2023 $1,141 · 2024 $1,098 · 2025 $976
Food & beverage: $976
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $205 |
| Novartis Pharmaceuticals Corporation | 6 | $163 |
| PFIZER INC. | 6 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $78 |
| ABBVIE INC. | 3 | $69 |
| Abbott Laboratories | 3 | $65 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Surgenex LLC | 1 | $29 |
| Boston Scientific Corporation | 1 | $28 |
Products named: Veozah, LEQVIO, Kerendia, NURTEC ODT, ELIQUIS, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, QULIPTA.
Industry payments across AZ — which companies pay providers there.
